ESMO20 YO for YO: highlights on metastatic renal cell carcinoma-the CheckMate-9ER trial.

ABSTRACT:

SUBMITTER: Kfoury M 

PROVIDER: S-EPMC7807955 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature